Contact Person
David Munis Zepernick

Head of Business Development and Public Affairs

Email: dz@mva.org
Phone: (M) +45 2498 1668
Linkedin

News

Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.

MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.

If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.

05 Jun

Servier completes the acquisition of MVA-member company Symphogen

Symphogen becomes the antibody center of excellence within Servier strengthening the Group’s pipeline Yesterday, Servier announced that it has completed the acquisition of Symphogen A/S. Symphogen will now function as the antibody center of excellence of Servier in several different

27 May

Medicon Valley Alliance, CEO, Petter Hartman, appointed member of Invest in Skåne’s Board of Directors

Invest in Skåne has just announced that MVA CEO, Petter Hartman, has been appointed member of Invest in Skåne’s Board of Directors. In a short interview, Petter Hartman, explains how and why he hopes to be able to contribute to

26 May

Open call for funding to support projects focusing on integrating digital innovations and disruptive technologies across the Medical Diagnostics

The DIGI-B-CUBE project launched an open call for funding on 22nd April 2020, to support projects focusing on integrating digital innovations and disruptive technologies across the Medical Diagnostics and related value chains. Small and Medium Enterprises (including new start-ups) operating

25 May

Top European Biotech Investors of 2019 and lessons learned

Our friends at the leading online biotech media, Labiotech.eu, recently published the article “What 2019 Can Teach About European Biotech Investments Going Forward” including among other things a list of Top European Biotech Investors of 2019. Among the highlights emphasized

13 May

Interview with Managing Director of Merck in Denmark, Enrique Alvarez, about Medicon Valley, healthcare reform AND fertility!

In today´s edition of the biweekly newsletter, MVA Update, we had the pleasure of publishing an interview with Managing Director of Merck in Denmark, Enrique Alvarez. We asked him a few questions about his international perspective on the framework conditions

12 May

COVID-19 patients in intensive care in the Capital Region, Region Zealand, Region Skåne and Region Stockholm

The discussion about how and when to open the Danish-Swedish border and the potential risk involved in allowing commuters to go to work again should be based on facts. Above a recently published analysis from News Øresund which points to

11 May

Interview with Canadian Ambassador to the Kingdom of Denmark, Emi Furuya about life science, Canada and COVID-19

Q1) How is Canada handling the Covid-19 crisis? There is no doubt that the COVID-19 crisis is affecting Canada, as it is affecting Denmark, and the entire world, in ways that are very hard to predict at the moment. Canada

30 Apr

Project from Wallenberg Centre for Molecular Medicine at Lund Stem Cell Center funded with DKK 3.5M in BioInnovation PreSeed program

In the recently opened call for the Nordic PreSeed Program by the COBIS-based, MVA-member, BioInnovation Institute, the project in dendritic cell therapy from the Medicon Valley based Wallenberg Centre for Molecular Medicine has been funded with 3.5 million DKK. ”I am

21 Apr

“Culture and strategy should dine together”, column by MVA Chairman of the Board of Directors, Søren Bregenholt, in Greater Copenhagen Life Science Yearbook 2020

Yes, MVA Chairman, Søren Bregenholt, gave the old Peter Drucker quote “Culture eats strategy for breakfast” a twist when describing his analysis of and ambitions for life science collaboration in the Medicon Valley cluster. But what is he actually trying